0001333277-21-000035.txt : 20210405
0001333277-21-000035.hdr.sgml : 20210405
20210405170029
ACCESSION NUMBER: 0001333277-21-000035
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210405
FILED AS OF DATE: 20210405
DATE AS OF CHANGE: 20210405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dorling Janet
CENTRAL INDEX KEY: 0001738144
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 21806290
MAIL ADDRESS:
STREET 1: C/O ACHAOGEN, INC.
STREET 2: 1 TOWER PLACE, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7575 GATEWAY BOULEVARD
STREET 2: SUITE 110
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7575 GATEWAY BOULEVARD
STREET 2: SUITE 110
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2021-04-05
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001738144
Dorling Janet
C/O CYMABAY THERAPEUTICS, INC.
7575 GATEWAY BOULEVARD, SUITE 110
NEWARK
CA
94560
1
0
0
0
Stock Option (right to buy)
4.63
2021-04-05
4
A
0
80000
0
A
2031-04-04
Common Stock
80000
80000
D
The option vests as to 1/36 of the underlying shares monthly from April 5, 2021.
/s/ Paul Quinlan, as attorney-in-fact for Janet Dorling
2021-04-05